Erica Zarse
Pediatric Endocrinology · Kansas City, MONPI 1972036523
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,572 and has fallen 78.5% since, to $338 in 2025.
Across 97 payments — averaging $30.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$534
- BETA Bionics, Inc.$314
- Novo Nordisk$295
- Tandem Diabetes Care, Inc.$286
- Dexcom, Inc.$192
- Regeneron Healthcare Solutions, Inc.$149
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,920100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 24 | $534 |
| BETA Bionics, Inc. | 3 | $314 |
| Novo Nordisk | 9 | $295 |
| Tandem Diabetes Care, Inc. | 8 | $286 |
| Dexcom, Inc. | 4 | $192 |
| Regeneron Healthcare Solutions, Inc. | 6 | $149 |
| Sanofi-aventis U.S. LLC | 5 | $131 |
| Amgen | 1 | $122 |
| Tolmar, Inc. | 5 | $118 |
| Corcept Therapeutics | 5 | $102 |
| AstraZeneca | 1 | $97 |
| Abbott | 4 | $77 |
| QOL Medical, LLC | 2 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $60 |
| Amphastar Pharmaceuticals, Inc. | 3 | $53 |
| Endo Pharmaceuticals Inc. | 2 | $44 |
| Xeris Pharmaceuticals, Inc. | 1 | $43 |
| Insulet Corporation | 2 | $41 |
| Mannkind Corporation | 2 | $36 |
| Amneal Pharmaceuticals LLC | 1 | $29 |
| Cequr Corporation | 2 | $26 |
| Ascendis Pharma Endocrinology Inc | 1 | $25 |
| Endo USA, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $23 |
| Pfizer | 1 | $15 |
| Medtronic | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,920 in reported general payments places this provider in the 80th percentile of 48 pediatric endocrinology providers in Missouri.
Other pediatric endocrinology in Kansas City
- Ryan McDonoughKansas City$195K
- Joseph CernichKansas City$25K
- Matthew FeldtKansas City$13K
- Michelle KnollKansas City$940
- Figen UgrasbulKansas City$903
- Melissa Kaori LitaoKansas City$819
- Julia BroussardKansas City$754
- Yun YanKansas City$651
- Cintya SchweisbergerKansas City$612
- Kavitha DileepanKansas City$504
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.